AUS
NZ
UK
CA
USA
IND
Highlights
- Pro Medicus lands major U.S. contract with top-tier university health system
- Implementation begins immediately, go-live expected later this year
- Move strengthens position among top-performing ASX200 healthcare stocks
Australian medical imaging software company Pro Medicus (ASX:PME) has signed a significant five-year, $20 million contract through its U.S. subsidiary, Visage Imaging, with the University of Iowa Health Care system. The agreement marks another milestone in the company’s international expansion and reinforces its foothold in the U.S. healthcare market.
The contract includes a full rollout of Pro Medicus' enterprise imaging platform across the university's extensive health network. With over 20,000 staff members, including 1,200 physicians and dentists, the University of Iowa operates one of the largest and most advanced academic health systems in the Midwest. The implementation will begin immediately, with a target go-live later this year.
This new partnership adds to Pro Medicus' track record of securing high-profile institutional clients in the United States. The platform’s capability to manage large-scale, high-volume radiology workflows was a key factor in the selection. Its advanced cloud-based architecture and AI-powered capabilities are aligned with the growing demand for scalable and intelligent medical imaging solutions.
The University of Iowa Health Care includes three campuses and provides care to thousands of patients daily, making it a significant operational win for Pro Medicus. The contract’s value—$20 million over five years—reflects not only the scope of the deployment but also the increasing confidence U.S. institutions are placing in Australian technology providers.
Pro Medicus continues to be closely watched among investors tracking high-performing healthcare technology firms within the ASX 200 index, which highlights 200 of the largest companies listed on the ASX.
With a strong cash position and a history of consistent profitability, Pro Medicus has also gained attention in discussions around potential future leaders in the space of ASX dividend stocks. Although the company has traditionally focused on reinvestment for growth, its expanding revenue base puts it in favorable view for those exploring dividend-paying options within the healthcare technology sector.
As the rollout progresses and the University of Iowa Health Care begins to fully implement the Visage platform, market observers will be watching for the impact this may have on broader adoption across similar U.S. institutions. The agreement further positions Pro Medicus as a key innovator in global medical imaging.
